Register for IPO Updates
Our Passion for IPOs
Largest Global IPOs
Largest US IPOs
Largest US IPOs YTD
Largest US Internet IPOs
Top First Day Returns
US IPO Stats
IPO Average Age
IPO Industry Breakdown
Offer Price Discounts
Global IPO Stats
IPOs by Region
IPO Industry Breakdown
Press Contact Form
AWARD WINNER 2015
North American ETF Provider
Follow us on g+
Like us on Facebook
Follow us on LinkedIn
Free iPhone App
Free Android App
IPO News Feed
IPO News Archive
New Ways to Invest in IPOs - IPO ETFs
IPO Market Shifts to Growth: 1Q10 Global Review
Analyst IPO Blog
With 100 deals and $45 billion in proceeds raised, the 1Q10 was the second best quarter for
issuance since the end of 2007. More importantly, signals of increasing risk appetite suggest that the market may be at an inflection point. We believe that the composition of the
is undergoing an important shift that has implications for both future issuance and the global economic outlook. Continuing a trend from late 2009, mature companies in cyclical industries dominated early first quarter deal flow, and investor sensitivity to valuations caused performance to suffer. However, with the number of global tech deals doubling from the 4Q09 and US venture-backed companies beginning to see daylight, we could be witnessing the revival of the IPO market's traditional growth sectors.
1Q 2010 global IPO issuance soars relative to a depressed 1Q 2009
Quarterly tallies of 100 deals and $45 billion in proceeds are light years ahead of those from the turbulent 1Q09, which saw only two IPOs raise a combined $0.9 billion in proceeds. Looking back to a more normalized market for context, the 1Q10 matched the 1Q07 in deal activity (100 versus 100) and exceeded the 1Q07 in terms of total proceeds raised ($45b versus $32b). Additionally, the 1Q07 represented only 18% of full-year 2007 deals and 13% of proceeds, suggesting that the
could get busier in the remainder of 2010.
China dominates deal flow; pulls up global performance
China led all markets in terms of deal flow for the third consecutive quarter, with 39 companies going public. However, it barely edged Japan on a total proceeds basis ($12.3 billion versus $11.4 billion), with leading Japanese insurance company Dai-ichi Life raising $11.0 billion in the largest global IPO since Visa. The average IPO returned 23.8% from its offer price, down slightly from 24.3% in the 4Q09. The median IPO return was 14.5%, with nearly three quarters of IPOs trading above their IPO prices. Overall, China-traded IPOs bolstered global returns with a blistering 44.8% average rise, and Shanghai accounted for 15 of the top 20 global performers. Specifically, five of the top 10 performers were China-traded tech companies; this group produced an impressive 111.8% average return. Not surprisingly, Asia Pacific was the top performing region with a 34.8% average return, while North America, Europe and Latin America lagged with 8.1%, 4.8% and 4.7% average gains, respectively. The top US performer, technology-enabled portfolio advisor Financial Engines (
), was the only North American deal in the top 20, with a 40.8% return from its offer price.
An Inflection Point in the US Market?
On a year-over-year basis, the number of US deals increased sharply to 27, though proceeds were up only four-fold as a result of the $720 million Bristol Myers Squibb carve-out of baby nutrition company Mead Johnson Nutrition (
) in the prior period. By comparison, the largest 1Q10 US deal was the $570 million offering of sensor and controls maker Sensata Technologies (
), and the average deal size declined to $162 million (down 60% from the 4Q) driven by a March surge in deals from smaller cap growth IPOs.
The largest US deals come from mature industries
In a continuation of a 2009 trend, private equity firms were behind three of the five largest US deals in the 1Q10, including Sensata Technologies, life insurer Symetra Financial and standby generator manufacturer Generac Holdings. Overall,
private equity-backed IPOs
represented 37% of proceeds raised in the first quarter of 2010, up from 30% for the full year 2009. Rounding out the top five were Primerica (
), a carve-out of Citi's life insurance business that priced on March 31, and Crude Carriers (
), a newly-formed shipping company.
Venture Capital Springs to Life in March
The US IPO market brought more positive signals as we moved into March. With Euro-zone debt concerns easing and the Fed renewing its commitment to record low interest rates, upward momentum in the broader market supported an increase in deal flow, particularly from the small cap tech and biotech sectors. On average, first day returns improved to 11.7% versus a -1.5% loss in January and February. Despite the shorter horizon, deals priced in March have returned 9.7%, versus 4.3% for earlier 1Q10 deals, and represent three of the quarter's top five gainers.
March also saw a welcome uptick in
venture capital-backed IPOs
(5), driving the highest quarterly total (9) since the end of 2007. These deals vastly outperformed their non-venture peers with a first day pop of 14.3% (versus -0.1%) and total return of 14.8% (versus 2.9%). Interestingly, this group included the largest biotech IPO since 2002 in Ironwood (
), and offerings from sectors that had been dormant since 2007, including fabless chip designed MaxLinear (
) and telecom equipment vendor Calix (
). The strong performance for these three deals suggests that US IPO investors are moving further out on the risk spectrum.
With the uptick in venture-backed activity and solid
, it is not surprising to see continued momentum in new filings from growth sectors. Growth-oriented technology and healthcare companies currently represent a quarter of prospective IPOs in the pipeline, and venture-backed companies accounted for 38% of new IPO filings in the 1Q10. While stable companies in mature industries continue to drive global issuance, performance is increasingly favoring the smaller and faster-growing companies that have historically been the engine of the IPO market. Particularly in the US, improving liquidity in the venture channel suggests that
, are looking beyond the deleveraging phase of the global recovery and toward the next sources of economic growth.
Note: All global statistics include IPOs that raised over $100 million in gross proceeds. US market statistics include IPOs with a proposed market cap above $50 million and exclude closed-end funds. Visit
for the full report and other
Keywords / Tickers:
Recently Priced IPOs
Global IPO Volume
ETF Express Award:
ETFExpress awards are based on a 'peer review system' whereby readers - including institutional and high net worth investors as well as managers and other industry professionals at fund administrators, brokers, custodians and advisers - are invited to elect a 'best in class' in a series of categories via an online survey. In each category, the firms with the most votes at the end of the voting period are subject to a final review by ETFExpress's Senior Editorial team.
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost. Investors should consider the investment objectives, risks, charges and expenses carefully before investing.
As stated in the Prospectus, the total annual operating expenses for the Fund was 3.48%. The Adviser has contractually agreed to keep net expenses from exceeding 2.50% of the Fund's average daily net assets for at least a year from the date of the Prospectus and for an indefinite period thereafter subject to annual re-approval of the agreement by the Board of Trustees.
An investor cannot invest directly in an index. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.
Definitions: Net Asset Value (NAV) of the fund is calculated by dividing the total value of all the securities in its portfolio, less any liabilities, by the number of fund shares outstanding. Market Price is current value at which an asset or service can be bought or sold. Premium/Discount is provided to show the comparison of the daily net asset value (NAV) and the midpoint of the closing bid/ask for each of the funds. The
Renaissance IPO Index® (IPOUSA)
is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios. The
Renaissance International IPO Index® (IPOXUS)
is a stock market index based upon a portfolio of newly public companies listed on non-U.S. exchanges. The S&P 500® Index (SPX) is a stock market index based on the market capitalizations of 500 large companies whose common stock is publicly traded on the NYSE.
Risk Disclosure: Investments in the
Renaissance IPO ETF, symbol "IPO"
Renaissance International IPO ETF, symbol "IPOS"
(the "ETFs"), and the
Global IPO Fund, symbol "IPOSX"
(the "Mutual Fund") are subject to investment risk, including possible loss of the principal amounts invested. The ETFs and the Mutual Fund (the "Funds") invest in companies that have recently completed initial public offerings. These stocks are unseasoned equities lacking trading history, a track record of reporting to investors and widely available research coverage which many result in extreme price volatility. Due to a greater number of IPOs in certain segments, the Funds may also be subject to information technology and financial sector risk, small and mid-capitalization company risk, and, for the Renaissance International IPO ETF, emerging markets risk. The Funds may hold securities in the form of Depository Receipts, REITs, and Partnership Units which have greater risks than common shares. The strategies have high portfolio turnover and securities lending risks. The returns of the ETFs may not match the return of the respective indices. The ETFs are classified as non-diversified investment companies subject to concentration risk.
Prospectus: Investors should consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus and/or summary prospectus with this and other information, please visit
. Read the prospectus carefully before investing. Renaissance Capital Investments, Inc., distributor for the Mutual Fund. Foreside Fund Services, LLC, distributor for the ETFs, 1-866-486-6645.
Definitions: The Renaissance IPO Index® is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios. The S&P 500® Index is a stock market index based on the market capitalizations of 500 large companies whose common stock is publicly traded on the NYSE.
The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital - manager of IPO-focused ETFs.
The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO), the Renaissance International IPO ETF (symbol: IPOS), or the Global IPO Fund (symbol: IPOSX), may have investments in securities of companies mentioned.
Register for Updates
Renaissance Capital LLC is an SEC-registered investment adviser.
Renaissance Capital Investments, Inc. is a
-registered broker-dealer, and member of
© 2015 Renaissance Capital LLC. All rights reserved.